These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11297250

  • 1. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN, Lakka SS, Kin Y, Konduri SD, Fuller GN, Mohanam S, Rao JS.
    Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
    [Abstract] [Full Text] [Related]

  • 2. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
    Konduri SD, Rao CN, Chandrasekar N, Tasiou A, Mohanam S, Kin Y, Lakka SS, Dinh D, Olivero WC, Gujrati M, Foster DC, Kisiel W, Rao JS.
    Oncogene; 2001 Oct 18; 20(47):6938-45. PubMed ID: 11687973
    [Abstract] [Full Text] [Related]

  • 3. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.
    Oncogene; 2003 Jul 17; 22(29):4509-16. PubMed ID: 12881707
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro.
    Konduri SD, Tasiou A, Chandrasekar N, Rao JS.
    Int J Oncol; 2001 Jan 17; 18(1):127-31. PubMed ID: 11115549
    [Abstract] [Full Text] [Related]

  • 5. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
    Plate KH, Breier G, Farrell CL, Risau W.
    Lab Invest; 1992 Oct 17; 67(4):529-34. PubMed ID: 1434531
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
    Konduri SD, Osman FA, Rao CN, Srinivas H, Yanamandra N, Tasiou A, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Kouraklis G, Rao JS.
    Oncogene; 2002 Jan 31; 21(6):921-8. PubMed ID: 11840337
    [Abstract] [Full Text] [Related]

  • 8. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo.
    Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, Rao JS.
    Cancer Res; 1994 Jul 15; 54(14):3656-61. PubMed ID: 8033079
    [Abstract] [Full Text] [Related]

  • 9. Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells.
    Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Rao JS.
    Int J Oncol; 2003 Jun 15; 22(6):1277-83. PubMed ID: 12738994
    [Abstract] [Full Text] [Related]

  • 10. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M.
    Clin Cancer Res; 2005 Jan 01; 11(1):267-72. PubMed ID: 15671555
    [Abstract] [Full Text] [Related]

  • 11. The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor.
    Yamahata H, Takeshima H, Kuratsu J, Sarker KP, Tanioka K, Wakimaru N, Nakata M, Kitajima I, Maruyama I.
    Int J Oncol; 2002 May 01; 20(5):921-8. PubMed ID: 11956584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.
    Zhang X, Fei Z, Bu X, Zhen H, Zhang Z, Gu J, Chen Y.
    J Surg Oncol; 2000 Jun 01; 74(2):90-4. PubMed ID: 10914816
    [Abstract] [Full Text] [Related]

  • 15. Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo.
    Yamamoto M, Sawaya R, Mohanam S, Loskutoff DJ, Bruner JM, Rao VH, Oka K, Tomonaga M, Nicolson GL, Rao JS.
    Cancer Res; 1994 Jul 01; 54(13):3329-32. PubMed ID: 8012944
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
    Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Oncogene; 2002 Aug 15; 21(36):5601-8. PubMed ID: 12165859
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
    Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H, Tomonaga M.
    Cancer Res; 1997 Jul 01; 57(13):2799-805. PubMed ID: 9205092
    [Abstract] [Full Text] [Related]

  • 18. Expression and localisation of urokinase-type plasminogen activator gene in gliomas.
    Zhang X, Bu XY, Zhen HN, Fei Z, Zhang JN, Fu LA.
    J Clin Neurosci; 2000 Mar 01; 7(2):116-9. PubMed ID: 10844794
    [Abstract] [Full Text] [Related]

  • 19. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
    Kitange G, Kishikawa M, Nakayama T, Naito S, Iseki M, Shibata S.
    Mod Pathol; 1999 Jun 01; 12(6):618-26. PubMed ID: 10392639
    [Abstract] [Full Text] [Related]

  • 20. Expression and significance of urokinase-type plasminogen activator in human gliomas.
    Zhang X, Bu X, Zhen H, Fei Z, Wu J, Gu J, Yi S, Wang Z.
    Chin Med J (Engl); 2000 Sep 01; 113(9):802-4. PubMed ID: 11776074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.